Streetbeat News

Stock Prices

AMD

BTCUSD

ETHUSD

SPY

Bitcoin and Ethereum have dropped by 2.5% amid modest ETF flows, raising questions about the cause of the decline. Meanwhile, Nvidia's rebound has helped the S&P 500 post its best week in 2024, despite the Greed Index remaining in the 'Fear' zone. AMD has expanded its AI capabilities by acquiring ZT Systems in a $4.9 billion deal.

Portfolio Pulse from Akanksha Bakshi

August 19, 2024 | 1:11 pm

KA

Kineta shares rose following the announcement of reopening patient enrollment for its VISTA-101 clinical trial.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:06 pm

IEP

The SEC has charged Carl Icahn and Icahn Enterprises L.P. for not disclosing the use of the company's securities as collateral for personal loans. This lack of transparency could have significant implications for investors and the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:05 pm

CBRL

Cracker Barrel is facing another proxy contest from Biglari Holdings, which has nominated five candidates for the company's Board of Directors. This marks the seventh proxy contest by Biglari in 13 years, with previous attempts being rejected by shareholders. Cracker Barrel's Board, led by new CEO Julie Masino, is focused on strategic transformation and will consider Biglari's nominations.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:03 pm

LIFW

MSP Recovery's stock is experiencing an uptick following the announcement of a $3.1 million settlement in an antitrust lawsuit.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:02 pm

NEM

Newmont (NYSE:NEM) has been analyzed by 7 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target has increased by 12.96% to $54.14. Analysts have raised their ratings and price targets, reflecting positive sentiment. Newmont's financials show strong profitability and growth, but high debt levels pose challenges.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 1:00 pm

BIIB

Analysts have provided mixed reviews for Biogen (NASDAQ:BIIB) over the past three months, with a range of bullish to bearish sentiments. The average 12-month price target has decreased slightly to $281.45. Biogen's financial health shows positive revenue trends and strong net margins, but it trails behind industry peers in growth rate.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 1:00 pm

BNTX

Analysts have mixed opinions on BioNTech (NASDAQ:BNTX), with a recent decrease in average price target by 1.23%. The company's financial health shows challenges, including a 23.26% revenue decline and negative net margins. Analysts' ratings range from 'Buy' to 'Underweight'.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 1:00 pm

CHUY

Analysts have provided mixed ratings for Chuy's Holdings (NASDAQ:CHUY) over the past three months, with a current average price target of $35.5, down from $38.10. The company's financial performance shows strong net margins and ROE, but revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 1:00 pm

FUBO

fuboTV shares are experiencing an increase in trading value following a judge's decision to temporarily block the Fox-Disney-Warner streaming venture, Venu.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:00 pm